(EMAILWIRE.COM, August 11, 2015 ) Alzheimers Disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline. During the early stages of disease, sleep disturbances and forgetfulness are generally the first presenting symptoms….
http://www.emailwire.com/release/195191-PharmaPoint-Alzheimers-Disease-Global-Drug-Forecast-and-Market-Analysis-Research-Shares-Size-and-Forecast-to-2023.html
PharmaPoint: Alzheimers Disease – Global Drug Forecast and Market Analysis, Research, Shares, Size and Forecast to 2023
Related Posts
Recent News
About Us
Market Press Newswire™ provides press release distribution services for businesses,organizations that provide market research reports. The press releases are published
across the webs. Other services include press release writing, editing,consulting and media planning.
Recent Post
Recent Posts
- Hydraulic Dosing Pump Market Size to Grow from USD 1.12 Billion in 2026 to USD 1.52 Billion by 2031 at 6.37% CAGR
- Tractor Market size to Reach USD 126.18 Billion by 2031 from USD 95.03 Billion in 2026, Driven by Mechanization Demand – Mordor Intelligence
- $42.8 Billion by 2032: 5 Unified Commerce Shifts Accelerating the Retail Point of Sale Market
- $712.4 Billion by 2032: 5 Wireless Connectivity Shifts Accelerating the 5G Market
Contact Us
MarketPressNewswire.net™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC